A randomised double blind controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease.

被引：1
|
作者：
Leiper, K
Woolner, JT
Parker, TJ
van der Vleit, M
Mullan, MM
Fear, S
Rhodes, JM
Hunter, JO
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Acad Hosp, Cambridge, England
[3] Roy Castle Int Ctr Lung Canc Res, Liverpool, Merseyside, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84470-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3032
引用
收藏
页码：A583 / A583
页数：1
相关论文
共 50 条
  • [11] NO CLINICAL BENEFIT OF PREBIOTICS IN THE TREATMENT OF ACTIVE CROHN'S DISEASE: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL
    Benjamin, J. L.
    Hedin, C. R. H.
    Koutsoumpas, A.
    Ng, S. C.
    Hart, A. L.
    Kamm, M. A.
    Sanderson, J. D.
    Knight, S. C.
    Forbes, A.
    Stagg, A. J.
    Whelan, K.
    Lindsay, J. O.
    GUT, 2010, 59 : A1 - A2
  • [12] No Clinical Benefit of Prebiotics in the Treatment of Active Crohn's Disease: A Double-Blind, Randomised, Placebo-Controlled Trial
    Benjamin, Jane L.
    Hedin, Charlotte R.
    Koutsoumpas, Andreas
    Ng, Siew C.
    Hart, Ailsa
    Kamm, Michael A.
    Sanderson, Jeremy D.
    Knight, Stella C.
    Forbes, Alastair
    Stagg, Andrew J.
    Whelan, Kevin
    Lindsay, James O.
    GASTROENTEROLOGY, 2010, 138 (05) : S614 - S614
  • [13] Randomised placebo controlled trial of clarithromycin in active Crohn's disease
    Leiper, Keith
    Martin, Kate
    Ellis, Tony
    Morris, Tony
    Watson, Alastair J.
    Rhodes, Jonathan M.
    GASTROENTEROLOGY, 2007, 132 (04) : A503 - A504
  • [14] Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial
    Escher, JC
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (01) : 47 - 54
  • [15] Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Sandborn, WJ
    Hanauer, SB
    Katz, S
    Safdi, M
    Wolf, DG
    Baerg, RD
    Tremaine, WJ
    Johnson, T
    Diehl, NN
    Zinsmeister, AR
    GASTROENTEROLOGY, 2001, 121 (05) : 1088 - 1094
  • [16] A controlled trial comparing ciprofloxacin with trial mesalazine for the treatment of active Crohn's disease.
    Colombel, JF
    Lemann, M
    Cassagnou, M
    Bouhnik, Y
    Duclos, B
    Dupas, JL
    Notteghem, B
    Mary, JY
    GASTROENTEROLOGY, 1997, 112 (04) : A951 - A951
  • [17] Budesonide (BUD) versus prednisone (PRED) in the treatment of active Crohn's disease (CD): A double-blind controlled trial.
    Bar-Meir, S
    GASTROENTEROLOGY, 1998, 114 (04) : A926 - A926
  • [18] Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease
    Herllinger, KR
    Witthoeft, T
    Raedler, A
    Bokemeyer, B
    Krummenerl, T
    Schulzke, JD
    Boerner, N
    Kueppers, B
    Emmrich, J
    Mescheder, A
    Schwertschlag, U
    Shapiro, M
    Stange, EF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (04): : 793 - 797
  • [19] Randomised placebo-controlled trial of clarithromycin in active Crohn's disease
    Leiper, K.
    Martin, K.
    Ellis, A.
    Morris, A. I.
    Watson, A. J. M.
    Rhodes, J. M.
    GUT, 2007, 56 : A114 - A114
  • [20] Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
    Dignass, Axel
    Stoynov, Simeon
    Dorofeyev, Andrey E.
    Grigorieva, Galina A.
    Tormova, Eva
    Altorjay, Istvan
    Tuculanu, Daniel
    Bunganic, Ivan
    Pokrotnieks, Juris
    Kupcinskas, Limas
    Dilger, Karin
    Greinwald, Roland
    Mueller, Ralph
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (09): : 970 - 980
12345